Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction
Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD.
Related Content:
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.